You have 9 free searches left this month | for more free features.

tazemetostat

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

Not yet recruiting
  • T-cell Lymphoma
  • CLL/SLL
  • Tazemetostat
  • Acalabrutinib and Tazemetostat
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2023

Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

Recruiting
  • Peripheral Nerve Sheath Tumor
  • Tazemetostat
  • Gainesville, Florida
    University of Florida
Jan 4, 2023

Relapsed/Refractory Lymphoma Trial in Shanghai (tazemetostat, HMPL-689)

Not yet recruiting
  • Relapsed/Refractory Lymphoma
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Feb 2, 2023

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Tazemetostat
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Boston, Massachusetts
  • +1 more
Oct 28, 2022

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Isehara, Chuo-ku (tazemetostat)

Completed
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Tazemetostat
  • Isehara, Kanagawa, Japan
  • +1 more
Apr 6, 2022

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Tazemetostat, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 26, 2022

Recurrent DLBCL Germinal Center B-Cell Type, Recurrent Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma Trial (Belinostat,

Not yet recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • +5 more
  • (no location specified)
Dec 2, 2022

Relapsed/Refractory Follicular Lymphoma With EZH2 Trial in Shanghai (Tazemetostat)

Not yet recruiting
  • Relapsed/Refractory Follicular Lymphoma With EZH2
  • Tazemetostat
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Jul 20, 2022

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Tazemetostat
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Non Small Cell Lung Cancer Trial in West Los Angeles (Tazemetostat)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Tazemetostat
  • West Los Angeles, California
    VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Jul 21, 2022

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • Tazemetostat
  • (no location specified)
Oct 17, 2022

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

Not yet recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Tazemetostat
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jul 31, 2022

Relapsed/Refractory Trial in Santa Fe (Tafasitamab, Lenalidomide, Tazemetostat)

Recruiting
  • Relapsed/Refractory
  • Santa Fe, California
    California Cancer Associates For Research And Excellence, cCARE
Feb 23, 2022

Sinonasal Carcinoma Trial (drug, procedure, other)

Not yet recruiting
  • Sinonasal Carcinoma
  • (no location specified)
Dec 9, 2021

COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome Trial (Tazemetostat)

Withdrawn
  • COVID-19 Acute Respiratory Distress Syndrome
  • Cytokine Release Syndrome
  • Tazemetostat
  • (no location specified)
Nov 17, 2021

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jan 13, 2023

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

Completed
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Tazemetostat
  • Nagoya, Aichi, Japan
  • +27 more
Nov 18, 2022

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting
  • All Malignancies
  • +11 more
  • Tazemetostat
  • +2 more
  • Encinitas, California
  • +9 more
May 20, 2022

B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2) Trial in Worldwide

Completed
  • B-cell Lymphomas (Phase 1)
  • +5 more
  • Tazemetostat
  • Birmingham, Alabama
  • +51 more
Dec 8, 2021

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • Tazemetostat
  • San Francisco, California
  • +31 more
Jan 17, 2023

Follicular Lymphoma Trial in United States (Tazemetostat, Rituximab)

Recruiting
  • Follicular Lymphoma
  • Tazemetostat
  • Rituximab
  • Birmingham, Alabama
  • +19 more
Mar 29, 2022